Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Comment by SamV21on Apr 25, 2021 3:20pm
112 Views
Post# 33063844

RE:RE:RE:RE:RE:RE:TBP-cash burn rate

RE:RE:RE:RE:RE:RE:TBP-cash burn rateI just think based on TBP history of selling off projects/patents after they don't have the capital to complete should be aproached with cautious optimism.I am happy about the sale price increase , no where near the 1.05 price I was trading this stock in 2018 , I don't short stock.Just because a product is produced and is successful does not mean it will be enbraced by the medical community, cost is always a factor.
Its all about the MONEY for everyone,even our 10% share owner who has been promoting TBP, I would do the same if I was holding over  37 million shares. I feel sorry for the people that bought in over a dollar and were lead to believe the company was going to the moon then as well.I will repeat I have not seen any medical Dr. even comment on this opioid replacement or in the main media, does not anyone else find that unusual ? Opioid deaths are a major issue in north america ,why has the medical community and the government  not paid any attention to TBP ?
<< Previous
Bullboard Posts
Next >>